Research Critique Paper
3. Maintain and improve physical conditioning through early exercise and mobility.21-28 [level C]
4. Elevate the head of bed (HOB) to 30º to 45º unless clinically contraindicated in patients receiving mechanical ventilation, as well as patients at high risk for aspiration.29-32 [level C]
5. Minimize pooling of secretions above the endo- tracheal tube cuff by using an endotracheal tube with subglottic suction capability in patients with anticipated intubation greater than 48 to 72 hours.33-39 [level C]
6. Change ventilator circuits only if visibly soiled; do not change ventilator circuits routinely.40-43 [level C]
AACN Practice Alert
Scope and Impact of the Problem Critically ill patients who are intubated are at risk
for development of ventilator-associated pneumonia (VAP). The National Healthcare Safety Network reported that the incidence of VAP for various types of hospital units is from 0.0 to 4.4 per 1000 ventilator days.1 Although reported incidence rates have been steadily declining, it remains unclear whether this decrease is related to prevention efforts, reporting defi nitions, or a combination of the two.
The mortality associated with VAP is signifi cant. Published mortality rates are from 0% to 70%, depend- ing on the population studied, clinical condition, and timing of VAP identification and antibiotic admin- istration. More recent meta-analyses report VAP- attributable mortality rates between 4.4% and 13%.2-6
Expected Nursing Practice 1. Collaborate to identify patients where implemen-
tation of noninvasive positive pressure ventilation (NIPPV) may be appropriate to prevent the need for intubation.7-9 [level C]
2. Assess readiness to extubate daily through com- bined spontaneous awakening trials (SATs: seda- tion interruption/minimization) and spontaneous breathing trials (SBTs), unless clinically contrain- dicated.10-20 [level C]
©2017 American Association of Critical-Care Nurses doi:https://doi.org/10.4037/ccn2017460
Prevention of Ventilator-Associated Pneumonia in Adults
AACN Levels of Evidence
Level A Meta-analysis of quantitative studies or metasynthesis of qualita tive studies with results that consis tently support a specifi c action, intervention, or treatment (including systematic review of randomized controlled trials)
Level B Well-designed, controlled studies with results that consistently support a specifi c action, intervention, or treatment
Level C Qualitative studies, descriptive or correlational studies, integrative reviews, systematic reviews, or randomized controlled trials with inconsistent results
Level D Peer-reviewed professional and organizational standards with the support of clinical study recommen- dations
Level E Multiple case reports, theory- based evidence from expert opinions, or peer-reviewed professional organizational standards without clinical studies to support recommendations
Level M Manufacturer’s recommendations only
e22 CriticalCareNurse Vol 37, No. 3, JUNE 2017 www.ccnonline.org
www.ccnonline.org CriticalCareNurse Vol 37, No. 3, JUNE 2017 e23
7. Perform oral care using chlorhexidine.44-56 [level C] 8. Use ventilator bundles to reduce ventilator-
associated events (VAEs) and VAP. [level C]
Supporting Evidence Avoiding Intubation
NIPPV is associated with lower pneumonia rates than is invasive mechanical ventilation.7-9
Assessing for Early Weaning and Mobility Implementation of paired SATs and SBTs may
reduce duration of mechanical ventilation/intubation, thereby reducing the risk of VAEs/VAP. Further, early exercise and mobilization reduce time to extubation, decrease length of stay, and support the return to independent function.10,17-19,57,58
Reducing Risk of Aspiration Microaspiration and macroaspiration of oral and
gastric secretions are suspected as key factors in the development of VAP. Aspiration may be increased by supine positioning and by collection of secretions above the endotracheal cuff. HOB elevation to greater than 30º to 45º may reduce aspiration of oral and gastric secre- tions associated with the supine position.31,59,60
Use of endotracheal tubes capable of continuous aspiration of subglottic secretions may reduce the inci- dence of VAP. Technologic advances in the design of endotracheal tube cuffs such as use of polyurethane and innovations in cuff shape may further reduce aspiration. Maintenance of optimal cuff pressures has also been recommended.33,35-39,61-64
Oral Care Application of chlorhexidine during routine oral
care reduces the incidence of VAP. Although this benefit may extend to all patients at risk for VAP, most evidence supports use of chlorhexidine primarily in cardiac surgery patients.44-56
Use of Ventilator Bundle Use of evidence-based bundled practices may reduce
VAP when the practices are consistently applied. These practices have been described as “ventilator bundles”
and are integrated into other recommendations such as the ABCDEF bundles.27,28,57,65-70
The Centers for Disease Control and Prevention (CDC) issued an updated framework in 2013 to clas- sify VAP within a more complex framework of VAEs.71 The purpose of the CDC framework was to create more precise surveillance definitions to overcome the limitation of traditional VAP surveillance definitions and to expand the framework to broader events and complications associated with mechanical ventilation. It is important to note that this framework was designed to guide surveillance only. It was not designed as a clini- cal framework to guide prevention and management of VAEs, including VAP. Within these guidelines, VAP is further defined as either “possible VAP” or “proba- ble VAP.” Probable VAP is the definition within the CDC framework that is closest to the traditional defi- nitions of VAP. The best available literature to guide improved outcomes in patients receiving mechanical ventilation continues to be publications aimed at the prevention of VAP and subsequently VAEs.
Implementation/Organizational Support for Practice
Ensure that the unit has written practice documents such as policies and procedures or practice guidelines regarding VAP prevention.
Determine your unit’s compliance rate with ventila- tor bundle interventions (eg, HOB elevation directive, use of subglottic suctioning, and performance of SAT/SBTs)
Develop an interprofessional task force to address practice changes related to preventing VAP/VAE.
Educate staff about the significance of hospital- acquired infections in the critically ill patients and how the interventions in the AACN’s VAP practice alert can reduce VAP/VAEs.
Incorporate educational content into orientation programs and monitor competency.
Incorporate interventions from this VAP practice alert in the unit’s standing orders and admission order sets.
Develop documentation standards as well as inte- gration of interventions from this VAP practice alert into clinical documentation (electronic health records).
e24 CriticalCareNurse Vol 37, No. 3, JUNE 2017 www.ccnonline.org
Need More Information or Help? 1. Go to www.aacn.org, click Clinical Resources,
and scroll down to select AACN Practice Resource Network.
2. Vollman K, Sole ML. Endotracheal tube and oral care. In: Wiegand D, ed. AACN Procedure Manual for Critical Care. 6th ed. St Louis, MO: Elsevier (Saunders); 2011.
3. Speck K, Rawat N, Weiner NC, Tujuba HG, Farley D, Berenholtz S. A systematic approach for developing a ventilator-associated pneumo- nia prevention bundle. Am J Infect Control. 2016; 44(6):652-656.
4. For more information on the ABCDEF bundle, access www.iculiberation.org.
5. CDC’s information on VAE and VAP: www.cdc.gov. 6. AACN Practice Alert: Oral Care for Acutely
and Critically Ill Patients. Crit Care Nurse. 2017; 37(3):e19-e21.
Original Author: Marianne Chulay, RN, PhD, FAAN February 2004
Contributing Author: John J. Gallagher, RN, MSN, CCNS, CCRN, RRT November 2016 Marianne Chulay, RN, PhD, FAAN January 2008
Approved by the Clinical Resources Task Force, December 2016.
Financial Disclosures None reported.
References 1. Dudeck MA, Weiner LM, Allen-Bridson K, et al. National Healthcare
Safety Network (NHSN) report, data summary for 2012, device-associated module. Am J Infect Control. 2013;41:1148-1166.
2. Agrafiotis M, Siempos II, Ntaidou TK, Falagas ME. Attributable mortal- ity of ventilator-associated pneumonia: a meta-analysis. Int J Tuberc Lung Dis. 2011;15(9):1154-1163.
3. Bekaert M, Timsit JF, Vansteelandt S, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011;184(10):1133-1139.
4. Melsen WG, Rovers MM, Koeman M, Bonten MJ. Estimating the attrib- utable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med. 2011;39(12):2736-2742.
5. Melsen WG, Rovers MM, Groenwold RH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13(8): 665-671.
6. Nguile-Makao M, Zahar JR, Francais A, et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteris- tics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med. 2010;36(5):781-789.
7. Burns KE, Meade MO, Premji A, Adhikari NK. Noninvasive positive- pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev. 2013;12:CD004127.
8. Carron M, Freo U, BaHammam AS, et al. Complications of non-invasive ventilation techniques: a comprehensive qualitative review of random- ized trials. Br J Anaesth. 2013;110(6):896-914.
9. Hess DR. Noninvasive positive-pressure ventilation and ventilator- associated pneumonia. Respir Care. 2005;50(7):924-929.
10. Balas MC, Vasilevskis EE, Olsen KM, et al. Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle. Crit Care Med. 2014;42(5): 1024-1036.
11. Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechani- cal ventilation of identifying patients capable of breathing spontaneously. N Engl J Med. 1996;335(25):1864-1869.
12. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.
13. Kollef MH, Shapiro SD, Silver P, et al. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med. 1997;25(4):567-574.
14. Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical venti- lation. N Engl J Med. 2000;342(20):1471-1477.
15. Lellouche F, Mancebo J, Jolliet P, et al. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med. 2006;174(8):894-900.
16. Marelich GP, Murin S, Battistella F, Inciardi J, Vierra T, Roby M. Proto- col weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: effect on weaning time and incidence of ventilator-associated pneumonia. Chest. 2000;118(2):459-467.
17. Mehta S, Burry L, Cook D, et al. Daily sedation interruption in mechan- ically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA. 2012;308(19):1985-1992.
18. Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med. 2004;32(6):1272-1276.
19. Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet. 2010;375(9713):475-480.
20. Yang L, Ye L, Zheng Z, Zhang M. Evaluation of the effectiveness and safety of the awakening and breathing coordination, delirium monitoring /management, and early exercise/mobility bundle: several confounders to be considered. Crit Care Med. 2014;42(10):e680-e681.
21. Bailey P, Thomsen GE, Spuhler VJ, et al. Early activity is feasible and safe in respiratory failure patients. Crit Care Med. 2007;35(1):139-145.
22. Burtin C, Clerckx B, Robbeets C, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009; 37(9): 2499-2505.
23. Lord RK, Mayhew CR, Korupolu R, et al. ICU early physical rehabilitation programs: financial modeling of cost savings. Crit Care Med. 2013; 41(3): 717-724.
24. Morris PE, Griffin L, Berry M, et al. Receiving early mobility during an intensive care unit admission is a predictor of improved outcomes in acute respiratory failure. Am J Med Sci. 2011;341(5):373-377.
25. Morris PE, Goad A, Thompson C, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008;36(8):2238-2243.
26. Needham DM, Korupolu R, Zanni JM, et al. Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project. Arch Phys Med Rehabil. 2010;91(4):536-542.
27. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874-1882.
28. Titsworth WL, Hester J, Correia T, et al. The effect of increased mobility on morbidity in the neurointensive care unit. J Neurosurg. 2012; 116(6): 1379-1388.
29. Alexiou VG, Ierodiakonou V, Dimopoulos G, Falagas ME. Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. J Crit Care. 2009; 24(4): 515-522.
30. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999; 354(9193): 1851-1858.
31. Lin HL, Yang LY, Lai CC. Factors associated with head-of-bed elevation compliance for prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol. 2014;35(5):596-597.
32. van Nieuwenhoven CA, Vandenbroucke-Grauls C, van Tiel FH, et al. Feasibility and effects of the semirecumbent position to prevent ventila- tor-associated pneumonia: a randomized study. Crit Care Med. 2006; 34(2):396-402.
33. Bouza E, Perez MJ, Munoz P, Rincon C, Barrio JM, Hortal J. Continu- ous aspiration of subglottic secretions in the prevention of ventilator- associated pneumonia in the postoperative period of major heart surgery. Chest. 2008;134(5):938-946.
www.ccnonline.org CriticalCareNurse Vol 37, No. 3, JUNE 2017 e25
34. Damas P, Frippiat F, Ancion A, et al. Prevention of ventilator-associated pneumonia and ventilator-associated conditions: a randomized controlled trial with subglottic secretion suctioning. Crit Care Med. 2015; 43(1): 22-30.
35. Frost SA, Azeem A, Alexandrou E, et al. Subglottic secretion drainage for preventing ventilator associated pneumonia: a meta-analysis. Aust Crit Care. 2013;26(4):180-188.
36. Hallais C, Merle V, Guitard PG, et al. Is continuous subglottic suctioning cost-effective for the prevention of ventilator-associated pneumonia?. Infect Control Hosp Epidemiol. 2011;32(2):131-135.
37. Lacherade JC, De Jonghe B, Guezennec P, et al. Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial. Am J Respir Crit Care Med. 2010;182(7):910-917.
38. Leasure AR, Stirlen J, Lu SH. Prevention of ventilator-associated pneu- monia through aspiration of subglottic secretions: a systematic review and meta-analysis. Dimens Crit Care Nurs. 2012;31(2):102-117.
39. Muscedere J, Rewa O, McKechnie K, Jiang X, Laporta D, Heyland DK. Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med. 2011; 39(8):1985-1991.
40. Dreyfuss D, Djedaini K, Weber P, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. Am Rev Respir Dis. 1991;143(4 pt 1):738-743.
41. Kollef MH, Shapiro SD, Fraser VJ, et al. Mechanical ventilation with or without 7-day circuit changes: a randomized controlled trial. Ann Intern Med. 1995;123(3):168-174.
42. Long MN, Wickstrom G, Grimes A, Benton CF, Belcher B, Stamm AM. Prospective, randomized study of ventilator-associated pneumonia in patients with one versus three ventilator circuit changes per week. Infect Control Hosp Epidemiol. 1996;17(1):14-19.
43. Lorente L, Lecuona M, Galvan R, Ramos MJ, Mora ML, Sierra A. Peri- odically changing ventilator circuits is not necessary to prevent ventila- tor-associated pneumonia when a heat and moisture exchanger is used. Infect Control Hosp Epidemiol. 2004;25(12):1077-1082.
44. Grap MJ, Munro CL, Hamilton VA, Elswick RK,Jr, Sessler CN, Ward KR. Early, single chlorhexidine application reduces ventilator-associated pneumonia in trauma patients. Heart Lung. 2011;40(5):e115-e122.
45. Jacomo AD, Carmona F, Matsuno AK, Manso PH, Carlotti AP. Effect of oral hygiene with 0.12% chlorhexidine gluconate on the incidence of nosocomial pneumonia in children undergoing cardiac surgery. Infect Control Hosp Epidemiol. 2011;32(6):591-596.
46. Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med. 2014;174(5):751-761.
47. Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumo- nia. Am J Respir Crit Care Med. 2006;173(12):1348-1355.
48. Kola A, Gastmeier P. Efficacy of oral chlorhexidine in preventing lower respiratory tract infections: meta-analysis of randomized controlled trials. J Hosp Infect. 2007;66(3):207-216.
49. Labeau SO, Van de Vyver K, Brusselaers N, Vogelaers D, Blot SI. Preven- tion of ventilator-associated pneumonia with oral antiseptics: a system- atic review and meta-analysis. Lancet Infect Dis. 2011;11(11):845-854.
50. Li J, Xie D, Li A, Yue J. Oral topical decontamination for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Hosp Infect. 2013;84(4):283-293.
51. Nicolosi LN, del Carmen Rubio M, Martinez CD, Gonzalez NN, Cruz ME. Effect of oral hygiene and 0.12% chlorhexidine gluconate oral rinse in preventing ventilator-associated pneumonia after cardiovascular sur- gery. Respir Care. 2014;59(4):504-509.
52. Ozcaka O, Basoglu OK, Buduneli N, Tasbakan MS, Bacakoglu F, Kinane DF. Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: a randomized clinical trial. J Periodont Res. 2012;47(5):584-592.
53. Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR. Oro- pharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control. Chest. 2009;135(5):1150-1156.
54. Shi Z, Xie H, Wang P, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev. 2013;8:CD008367.
55. Silvestri L, Weir I, Gregori D, et al. Effectiveness of oral chlorhexidine on nosocomial pneumonia, causative micro-organisms and mortality in critically ill patients: a systematic review and meta-analysis. Minerva Anestesiol. 2014;80(7):805-820.
56. Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V. Ran- domized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associ- ated pneumonia. Infect Control Hosp Epidemiol. 2008;29(2):131-136.
57. Klompas M, Anderson D, Trick W, et al. The preventability of ventilator- associated events: the CDC prevention epicenters wake up and breathe collaborative. Am J Respir Crit Care Med. 2015;191(3):292-301.
58. Kress JP, Hall JB. The changing landscape of ICU sedation. JAMA. 2012; 308(19): 2030-2031.
59. Hiner C, Kasuya T, Cottingham C, Whitney J. Clinicians’ perception of head-of-bed elevation. Am J Crit Care. 2010;19(2):164-167.
60. Wolken RF, Woodruff RJ, Smith J, Albert RK, Douglas IS. Observational study of head of bed elevation adherence using a continuous monitoring system in a medical intensive care unit. Respir Care. 2012;57(4):537-543.
61. Damas P, Frippiat F, Ancion A, et al. Prevention of ventilator-associated pneumonia and ventilator-associated conditions: a randomized controlled trial with subglottic secretion suctioning. Crit Care Med. 2015; 43(1):22-30.
62. Fernandez JF, Levine SM, Restrepo MI. Technologic advances in endo- tracheal tubes for prevention of ventilator-associated pneumonia. Chest. 2012;142(1):231-238.
63. Loupec T, Petitpas F, Kalfon P, Mimoz O. Subglottic secretion drainage in prevention of ventilator-associated pneumonia: mind the gap between studies and reality. Crit Care. 2013;17(6):R286.
64. Rouze A, Nseir S. Continuous control of tracheal cuff pressure for the prevention of ventilator-associated pneumonia in critically ill patients: where is the evidence? Curr Opin Crit Care. 2013;19(5):440-447.
65. Alroumi F, Sarwar A, Grgurich PE, Lei Y, Hudcova J, Craven DE. Strate- gies for prevention of ventilator-associated pneumonia: bundles, devices, and medications for improved patient outcomes. Hosp Pract (1995). 2012;40(1):81-92.
66. Alvarez Lerma F, Sanchez Garcia M, Lorente L, et al. Guidelines for the prevention of ventilator-associated pneumonia and their implementation: the Spanish “zero-VAP” bundle. Med Intensiva. 2014;38(4):226-236.
67. Croce MA, Brasel KJ, Coimbra R, et al. National Trauma Institute pro- spective evaluation of the ventilator bundle in trauma patients: does it really work?. J Trauma Acute Care Surg. 2013;74(2):354-360.
68. Perez-Granda MJ, Barrio JM, Munoz P, Hortal J, Rincon C, Bouza E. Impact of four sequential measures on the prevention of ventilator-associated pneumonia in cardiac surgery patients. Crit Care. 2014;18(2):R53.
69. Rosenthal VD, Rodrigues C, Alvarez-Moreno C, et al. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents: findings of the International Nosocomial Infection Control Consortium. Crit Care Med. 2012;40(12):3121-3128.
70. ICU Liberation. ABCDEF Bundle. http://www.iculiberation.org/Bundles /Pages/default.aspx. Accessed February 24, 2017.
71. Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for ventilator-associated events: executive sum- mary. Clin Infect Dis. 2013;57(12):1742-1746.
Copyright of Critical Care Nurse is the property of American Association of Critical-Care Nurses and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.